10-Q: Global Innovative Platforms Reports Q1 2025 Results, Cites Going Concern Uncertainty

Global Innovative Platforms reports a net loss for the quarter ended December 31, 2024, and acknowledges substantial doubt about its ability to continue as a going concern.

Summary

• Global Innovative Platforms Inc. reported its financial results for the three months ended December 31, 2024.
• The company incurred a net loss of $120,467, compared to a net loss of $49,469 for the same period in 2023.
• The company recognized no revenue during the three months ended December 31, 2024 and 2023.
• General and administrative expenses increased to $120,467 from $49,469 in the prior year, driven by increased research and consulting costs.
• As of December 31, 2024, the company's cash and cash equivalents totaled $148,459, a significant increase from $15 as of September 30, 2024.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company is dependent on raising additional equity and/or debt to meet its ongoing operating expenses.
• As of January 29, 2025, there were 39,111,241 shares of common stock issued and outstanding.
• Subsequent to the quarter end, on January 29, 2025, the company issued and sold 1,810,000 shares of its common stock for $181,000.

Sentiment

Score: 3

Explanation: The sentiment is low due to the significant net loss, lack of revenue, going concern warning, and material weaknesses in internal controls. While the company has raised some capital, the overall financial situation is precarious.

Positives

• Cash and cash equivalents increased significantly to $148,459 as of December 31, 2024.
• The company raised $286,500 through the issuance of common stock during October and December 2024.
• The company converted $337,360 of debt into equity, improving its balance sheet.

Negatives

• The company reported a net loss of $120,467 for the quarter ended December 31, 2024.
• The company had no revenue for the quarter.
• General and administrative expenses increased significantly.
• The company's independent auditors have expressed substantial doubt about its ability to continue as a going concern.
• The company lacks a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with its financial reporting requirements.

Risks

• The company's ability to continue as a going concern is dependent on raising additional debt or equity funding.
• The company has no committed source for any funds.
• The company may not be able to carry out its business plan if it cannot raise funds when needed.
• The company has material weaknesses in its internal control over financial reporting.
• The company is dependent upon its controlling shareholder to provide continued funding and capital resources.

Future Outlook

The company intends to raise capital to finance its future operations and is seeking opportunities for growth in return for shares of its common stock to create value for its shareholders.

Management Comments

• The Company's plan of operation is to obtain debt or equity finance to meet our ongoing operating expenses and opportunities for growth in return for shares of our common stock to create value for our shareholders.
• The Company will need substantial additional capital to support its budget.
• The Company has no committed source for any funds as of date hereof.
• In the event funds cannot be raised when needed, the Company may not be able to carry out its business plan, may never achieve sales or royalty income, and could fail in business as a result of these uncertainties.

Industry Context

The company operates in the competitive market of measuring gas outflow in pets and agriculture for diagnosis treatment of illness, requiring continuous innovation and capital raising to stay competitive.

Comparison to Industry Standards

• Without specific revenue or growth metrics, it's difficult to compare Global Innovative Platforms to industry standards.
• Many early-stage companies in similar sectors rely on venture capital or angel investors for funding, a strategy Global Innovative Platforms appears to be pursuing through stock issuances.
• Companies like Zoetis (ZTS) and IDEXX Laboratories (IDXX) are established players in the animal health market, with significant revenue and R&D investments, representing a stark contrast to Global Innovative Platforms' current financial state.

Legal Proceedings

• We were not subject to any legal proceedings during the three months ended December 31, 2024 or December 31, 2023 and, to the best of our knowledge, no legal proceedings are pending or threatened.

Related Party Transactions

• On October 23, 2023, the Company issued 24,532,138 shares of common stock, par value $0.0001 per share, including 18,271,990 which was issued to related parties for an aggregate consideration of $1,827.
• The Company also issued 600,000 shares of our common stock on September 27, 2024 for an aggregate consideration of $60,000.
• On July 10, 2024, the Company issued 530,000 shares of our common stock, par value of $0.0001 per share, which included 490,000 shares to related parties in exchange for services of $49, including office space, secretarial and administrative services provided by members of the Company's founding team.
• As of September 28, 2024, the Company issued 2,197,000 shares of our common stock, par value of $0.0001 per share including 1,830,000 shares to related parties in exchange for services of $183 including office space, secretarial and administrative services provided by members of the Company's management and founding team.
• Three Shareholders advanced us $50,000, $50,000, and $1,115 for the year ended September 30, 2023 and an additional $25,000, for the year ending September 30, 2024.
• In October and December, 2024, the Company issued 3,555,750 shares for $286,500 in cash, $75 of stock subscriptions and $1,188 of services, of which 500,000 shares were issued to related parties for services valued at $850.
• We also paid a related party for $4,500 in rent for the quarter ended December 31, 2024.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern uncertainty and potential dilution from future equity issuances.
• Employees face uncertainty regarding job security due to the company's financial instability.
• Customers and suppliers may be hesitant to engage with the company due to its financial challenges.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company intends to raise capital to finance its future operations.
• The company plans to seek opportunities for growth in return for shares of its common stock to create value for its shareholders.
• The company intends to take appropriate and reasonable steps to make the necessary improvements to remediate the deficiencies in internal control.

Key Dates